Organogenesis Holdings Stock Up After Strong Fourth Quarter and Fiscal Year 2021 Financial Results
Organogenesis Holdings Inc. (NASDAQ: ORGO) shares up about 25% after the regenerative medicine company reported financial results for the fourth quarter and the year ended December 31, 2021 and introduced financial guidance for the fiscal year ending December 31, 2022....